|
![]() ![]() |
||||||||||||||||
![]() ![]() ![]() |
|
||||||||||||||||
![]() |
||
|
Volume: 23S7 - November 1997 CONTROLLING ANTIMICROBIAL RESISTANCE Appendix III LIST OF WORKING GROUPSGeneral Chairperson: Dr. Micheal Brazeau; GROUP I HOW TO IMPROVE ANTIBIOTIC/ANTIMICROBIAL USE Chair: Dr. Roger Thomas Group I A: Use of antimicrobial agents in community settings including day-care settings Chair: Dr. Hilary Robinson Group I B: Use of antimicrobial agents in acute care institutional health settings Chair: Dr. Geoffrey Taylor Group I C: Use of antimicrobial agents in chronic care settings including long-term care, hospices and correctional facilities Chair: Dr. Lindsay Nicolle Group I D: Perception of how antibiotics/antimicrobials are used Chair: Ms. Leanne Jardine-Tweedie GROUP II DETECTING ANTIMICROBIAL RESISTANCE: SURVEILLANCE AND LABORATORY ISSUES Chair: Dr. Gilles Delage Group II A: Detecting antibiotic resistance in community settings including day care Chair: Dr. James Talbot Group II B: Detecting antibiotic resistance in acute care institutional settings Chairs: Group II C: Detecting antibiotic resistance in long-term care facilities, hospices, correctional facilities and other institutional settings Chairs: Group II D: Detecting antibiotic resistance in animal or agricultural settings Chair: Dr. Carlton Gyles GROUP III WORKING TOGETHER Chair: Ms. Carol Clemenhagen Group III A: Creating partnerships with industry, government, health care providers, researchers, the media Chair: Dr. Allan Ronald Group III B: Co-ordinating care of individuals with antimicrobial-resistant organisms Chair: Ms. Catherine Mindorff GROUP IV MAKING SURE IT WORKS Chair: Dr. Lynn Johnson Group IV A: Developing a communication strategy for the integrated action plan Chair: Dr. Alison Bell Group IV B: Creating an audit strategy for the integrated action plan Chair: Dr. Paul Sockett
[Previous]
[Table of Contents] [Next] |
![]() |
|||
![]() |
Last Updated: 2002-11-08 | ![]() |